{
  "concept_id": "5717",
  "concept_data": {
    "title": "leukaemia",
    "category_code": "2841",
    "category_name": "health",
    "category_full": "2841 health",
    "is_redirect": true,
    "preferred_term": "blood disease",
    "relation_type": "USE"
  },
  "summary": "Leukaemia, classified under the broader category of \"blood disease,\" is a significant health concern within EU regulatory frameworks. As a redirect term, it highlights the importance of recognizing leukaemia as a specific manifestation of blood diseases, which are subject to various health regulations and directives aimed at disease prevention, treatment, and research funding. The EU prioritizes public health initiatives that address blood diseases, including leukaemia, through legislation that ensures access to necessary medical care and promotes research into innovative therapies. Understanding this classification is crucial for effective policy-making and resource allocation in the healthcare sector.",
  "metadata": {
    "generation_date": "2025-07-29T20:35:28.691783",
    "model_used": "gpt-4o-mini",
    "summary_length_target": 100,
    "actual_word_count": 95,
    "vocabulary_stats": {
      "total_related_words": 0,
      "selected_words": 0
    },
    "related_words": [],
    "prompt_length": 1188,
    "category": "2841 health"
  }
}